Altimmune
ALT
ALT
37 hedge funds and large institutions have $46.4M invested in Altimmune in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 36 → 37 (+1)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
37
Holding in Top 10
3
Calls
$147K
Puts
$63K
Top Buyers
| 1 | +$4.87M | |
| 2 | +$2.71M | |
| 3 | +$1.59M | |
| 4 |
SC
Sophrosyne Capital
New York
|
+$892K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$289K |
Top Sellers
| 1 | -$136K | |
| 2 | -$97K | |
| 3 | -$92K | |
| 4 |
PCM
Potomac Capital Management
New York
|
-$84.4K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$48.9K |